“Promising therapies such as CAR T cell therapy, bispecific antibodies, immunotherapy, among others have been in the market for almost a decade, and remain a dream for access in many countries,” explains Dr. Malpica Castillo.

Luis Malpica Castillo, MD

The University of Texas M.D. Anderson Cancer Center